References
- Bagdonaite, I., Nordén, R., Joshi, H. J., Dabelsteen, S., Nyström, K., Vakhrushev, S. Y., Olofsson, S., & Wandall, H. H. (2015). A strategy for O-glycoproteomics of enveloped viruses-the O-glycoproteome of herpes simplex virus type 1. PLoS Pathogens, 11(4), e1004784. https://doi.org/https://doi.org/10.1371/journal.ppat.1004784
- Bhardwaj, V. K., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2020). Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics,1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1766572
- Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., … Wang, C. (2020). A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. The New England Journal of Medicine, 382(19), 1787–1799. https://doi.org/https://doi.org/10.1056/NEJMoa2001282
- Chan, K. S., Lai, S. T., Chu, C. M., Tsui, E., Tam, C. Y., & Wong, M. M. (2003). Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: A multicentre retrospective matched cohort study. Hong Kong Medical Journal, 9(6), 399–406.
- Chen, J., Lee, K. H., Steinhauer, D. A., Stevens, D. J., Skehel, J. J., & Wiley, D. C. (1998). Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell, 95(3), 409–417. https://doi.org/https://doi.org/10.1016/S0092-8674(00)81771-7
- Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. https://doi.org/https://doi.org/10.1002/jmv.25681
- Chen, Y. W., Yiu, C. B., & Wong, K. Y. (2020). Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research, 9, 129. doi: https://doi.org/https://doi.org/10.12688/f1000research.22457.1
- Chu, C. M., Cheng, V. C., Hung, I. F., Wong, M. M., Chan, K. H., & Chan, K. S. (2004). Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax, 59(3), 252–256. https://doi.org/https://doi.org/10.1136/thorax.2003.012658
- Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Research, 176, 104742. https://doi.org/https://doi.org/10.1016/j.antiviral.2020.104742
- Cui, J., Li, F., & Shi, Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17(3), 181–192. https://doi.org/https://doi.org/10.1038/s41579-018-0118-9
- Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., Chevenet, F., Dufayard, J.-F., Guindon, S., Lefort, V., Lescot, M., Claverie, J.-M., & Gascuel, O. (2008). Phylogeny.fr: Robust phylogenetic analysis for the non-specialist. Nucleic Acids Research, 36(Web Server issue), W465–W469. https://doi.org/https://doi.org/10.1093/nar/gkn180
- Fung, T. S., & Liu, D. X. (2019). Human coronavirus: Host-pathogen interaction. Annual Review of Microbiology, 73(1), 529–557. https://doi.org/https://doi.org/10.1146/annurev-micro-020518-115759
- Gupta, R., & Brunak, S. (2002). Prediction of glycosylation across the human proteome and the correlation to protein function. In Pacific Symposium on Biocomputing, 7, 310–322.
- Havranek, B., & Islam, S. M. (2020). An in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease. Journal of Biomolecular Structure and Dynamics, 38, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1776158
- Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.052
- Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet, 395(10223), 497–506. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30183-5
- Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., & Mamun, A. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1761883
- Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019). TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. Journal of Virology, 93(6), 18. https://doi.org/https://doi.org/10.1128/JVI.01815-18
- Jin, Y. H., Cai, L., Cheng, Z. S., Cheng, H., Deng, T., & Fan, Y. P. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research, 7, 1–23. https://doi.org/https://doi.org/10.1186/s40779-020-0233-6
- Julenius, K., Mølgaard, A., Gupta, R., & Brunak, S. (2005). Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology, 15(2), 153–164. https://doi.org/https://doi.org/10.1093/glycob/cwh151
- Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012). Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. Journal of Virology, 86(12), 6537–6545. https://doi.org/https://doi.org/10.1128/JVI.00094-12
- Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1751298
- Lai, S. T. (2005). Treatment of severe acute respiratory syndrome. European Journal of Clinical Microbiology & Infectious Diseases, 24(9), 583–591. https://doi.org/https://doi.org/10.1007/s10096-005-0004-z
- Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/https://doi.org/10.1107/S0021889892009944
- Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., … Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/https://doi.org/10.1056/NEJMoa2001316
- Lythgoe, M. P., & Middleton, P. (2020). Ongoing Clinical Trials for the Management of the COVID-19 Pandemic. Trends in Pharmacological Sciences, 41(6), 363–382. https://doi.org/https://doi.org/10.1016/j.tips.2020.03.006
- Millet, J. K., & Whittaker, G. R. (2015). Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Research, 202, 120–134. https://doi.org/https://doi.org/10.1016/j.virusres.2014.11.021
- Molina, J.-M., Andrade-Villanueva, J., Echevarria, J., Chetchotisakd, P., Corral, J., David, N., Moyle, G., Mancini, M., Percival, L., Yang, R., Thiry, A., & McGrath, D. (2008). Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. The Lancet, 372(9639), 646–655. https://doi.org/https://doi.org/10.1016/S0140-6736(08)61081-8
- Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., Xiang, Z., Mu, Z., Chen, X., Chen, J., Hu, K., Jin, Q., Wang, J., & Qian, Z. (2020). Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications, 11(1), 1620. https://doi.org/https://doi.org/10.1038/s41467-020-15562-9
- Patick, A. K., & Potts, K. E. (1998). Protease inhibitors as antiviral agents. Clinical Microbiology Reviews, 11(4), 614–627. https://doi.org/https://doi.org/10.1128/CMR.11.4.614
- Poli, G., Granchi, C., Rizzolio, F., & Tuccinardi, T. (2020). Application of MM-PBSA methods in virtual screening. Molecules, 25(8), 1971. https://doi.org/https://doi.org/10.3390/molecules25081971
- Rao, S. N., Head, M. S., Kulkarni, A., & LaLonde, J. M. (2007). Validation studies of the site-directed docking program LibDock. Journal of Chemical Information and Modeling, 47(6), 2159–2171. https://doi.org/https://doi.org/10.1021/ci6004299
- Reinke, L. M., Spiegel, M., Plegge, T., Hartleib, A., Nehlmeier, I., Gierer, S., Hoffmann, M., Hofmann-Winkler, H., Winkler, M., & Pöhlmann, S. (2017). Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. PLoS One, 12(6), e0179177. https://doi.org/https://doi.org/10.1371/journal.pone.0179177
- Rice, P., Longden, I., & Bleasby, A. (2000). EMBOSS: The European Molecular Biology Open Software Suite. Trends in Genetics: TIG, 16(6), 276–277. https://doi.org/https://doi.org/10.1016/S0168-9525(00)02024-2
- Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020). High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerging Infectious Diseases, 26(7) 1470–1477. https://doi.org/https://doi.org/10.3201/eid2607.200282
- Shirato, K., Kawase, M., & Matsuyama, S. (2018). Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. Virology, 517, 9–15. https://doi.org/https://doi.org/10.1016/j.virol.2017.11.012
- Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Söding, J., Thompson, J. D., & Higgins, D. G. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Molecular Systems Biology, 7, 539. https://doi.org/https://doi.org/10.1038/msb.201175
- Simossis, V. A., & Heringa, J. (2005). PRALINE: A multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Research, 33(Web Server issue), W289–W294. https://doi.org/https://doi.org/10.1093/nar/gki390
- Tu, Y.-F., Chien, C.-S., Yarmishyn, A. A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S.-J., Yang, Y.-P., Wang, M.-L., & Chiou, S.-H. (2020). A review of SARS-CoV-2 and the ongoing clinical trials. International Journal of Molecular Sciences, 21(7), 2657. https://doi.org/https://doi.org/10.3390/ijms21072657
- Ul Qamar, M. T., Alqahtani, S. M., Alamri, M. A., & Chen, L. L. (2020). Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 10(4), 313–319. https://doi.org/https://doi.org/10.1016/j.jpha.2020.03.009
- Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181(2), 281–292. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.058
- Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., & Hu, Y. (2020). Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 395, 1569–1578. https://doi.org/https://doi.org/10.1016/S0140-6736(20)31022-9
- Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019). Exploitation of glycosylation in enveloped virus pathobiology. Biochimica et Biophysica Acta. General Subjects, 1863(10), 1480–1497. https://doi.org/https://doi.org/10.1016/j.bbagen.2019.05.012
- Wilson, S., Greer, B., Hooper, J., Zijlstra, A., Walker, B., Quigley, J., & Hawthorne, S. (2005). The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. The Biochemical Journal, 388(Pt 3), 967–972. https://doi.org/https://doi.org/10.1042/BJ20041066
- Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367(6483), 1260–1263. https://doi.org/https://doi.org/10.1126/science.abb2507
- Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., Tamamura, H., Fujii, N., & Yamamoto, N. (2004). HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochemical and Biophysical Research Communications, 318(3), 719–725. https://doi.org/https://doi.org/10.1016/j.bbrc.2004.04.083
- Yang, H., Bartlam, M., & Rao, Z. (2006). Drug design targeting the main protease, the Achilles' heel of coronaviruses. Current Pharmaceutical Design, 12(35), 4573–4590. https://doi.org/https://doi.org/10.2174/138161206779010369
- Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/https://doi.org/10.1073/pnas.1835675100
- Zhang, L., & Liu, Y. (2020). Potential interventions for novel coronavirus in China: A systematic review. Journal of Medical Virology, 92(5), 479–490. https://doi.org/https://doi.org/10.1002/jmv.25707
- Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6, 14. https://doi.org/https://doi.org/10.1038/s41421-020-0153-3
- Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., & Simmons, G. (2015). Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research, 116, 76–84. https://doi.org/https://doi.org/10.1016/j.antiviral.2015.01.011
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W., & China Novel Coronavirus Investigating and Research Team. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017
- Ziebuhr, J. (2005). The coronavirus replicase. Current Topics in Microbiology and Immunology, 287, 57–94. https://doi.org/https://doi.org/10.1007/3-540-26765-4_3